Avoiding hyperoxemia at the start of cardiopulmonary bypass while optimizing gas flow and temperature

Journal of Extra-Corporeal Technology

Volumn 31, Issue 3, 1999, Pages 145-151

  Myers, Gerard J ^a   Légaré, Jean François ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Blood gases; Cardiopulmonary bypass; Hyperoxemia; Normoxemia; Oxygen free radical; Oxygenation; Temperature

Indexed keywords

ALBUMIN; CARBON DIOXIDE; NITRIC OXIDE; NORMOSOL; OXYGEN; OXYGEN RADICAL;

ACIDOSIS; ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXTRACORPOREAL CIRCULATION; GAS FLOW; HUMAN; HYPEROXIA; OXYGEN CONCENTRATION; OXYGENATION; OXYGENATOR; TEMPERATURE;

EID: 0033373463     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kuntz RA, Maurer WG. An examination of cavitation as it relates to the extracorporeal arterial infusion model. J Extra-Corp Technol. 1982;14:345-154.
2. Pugsley W. The use of Doppler ultrasound in the assessment of microemboli during cardiac surgery. Perfusion. 1989;4:115-22.
3. Gravlee GP. Cardiopulmonary Bypass Principles and Practice. Baltimore: Williams & Wilkins, 1993;271.
4. Nijhoff M. Microembolization: Etiology and Prevention. In: M. Hilberman ed. Brain Injury and Protection During Heart Surgery. Dordrecht: Kluwer Academic, 1998;67-83.
5. Belboul A, Al-Khaja N, Ericson C, et al. The effects of hyperoxia during cardiopulmonary bypass on blood cell rheology and postoperative morbidity associated with cardiac surgery. J Extra-Corp Technol. 1991;23:43-48.
6. Ihnken K, Winkler A, Schlensak C, et al. Normoxemic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg. 1998;116:327-34.
7. Abbruzzese PA, Meloni L, Cardu G, et al. Role of arterial filters in the prevention of systemic embolization by microbubbles released by oxygenators. Am J Cardiol 1991; 67:911-12.
8. Fried DW, DeBenedetto B, Leo JJ, et al. Clinical oxygen transfer performance of the Sorin Monolyth membrane oxygenator. Perfusion 1994;9:119-26.
9. Ihnken K, Morita K, Buckberg G, et al. Studies of hyperoxemic reoxygenation injury with aortic clamping: XI. Cardiac advantage of normoxemic versus hyperoxemic management during cardiopulmonary bypass. J Thorac Cardiovas Surg. 1995;110:1255-64.
10. Ihnken K, Morita K, Buckberg G, et al. Nitric oxide-induced reoxygenation injury in the cyanotic immature heart is prevented by controlling oxygen content during initial reoxygenation. Angiology 1997;48:189-202.
11. Clark RE, Dietz DR, Miller JG. Continuous detection of microemboli during CPB in animals and man. Circulation 1976;54:111/74-78.
12. Krebber HT. Gasembolien wahrend operationen am offonen herzen. Fortschr Med. 1983;101:322-24.
13. Pearson DT. Gaseous microemboli. In: Taylor KM, ed. Cardiopulmonary Bypass Principles and Management. London: Chapman & Hall; 1986;315-35.
14. Swan H, Sanchez M, Tyndall M, et al. Quality control of perfusion: Monitoring venous blood oxygen tension to prevent hypoxic acidosis. J Thorac Cardiovasc Surg. 1990; 99:868-72.
15. 2 during cardiopulmonary bypass. Can Perf Can. 1996;9:9-11.